Jason Valentine is a chemist by training with an honours degree in In-organic chemistry. He was the first analytical scientist employed by Faulding Pharmaceuticals in 1994 to support the establishment of the Faulding drug studies unit bioanalytical facility. Faulding was the forerunner to CMAX, the first Phase 1 unit established in Australia.
In 1999, Jason transitioned to the University of South Australia to manage the Centre for Pharmaceutical Research Bioanalytical capability. Jason lead the expansion of the Centre to add CRO services to support the biotech and pharmaceutical industry and in 2009 drove the fund raising to spin off of the private company CPR Pharma Services out of the University. As the Founding CEO of CPR Pharma Services, Jason grew this entity to be a significant CRO with national relevance in early phase clinical trial activities. In 2018, CPR Pharma Services was acquired and split to form Agilex Biolabs (Bioanalytical Services) which Jason Leads as CEO.
With 25 years’ experience in Tandem Mass Spec Bio-assay development and validation coupled with FDA and EMA regulatory requirements for bioanalytical assays, Jason is a leader in the field of regulated bioanalysis. He is also a Graduate of the Australian Institute of Company Directors (GAIC).
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948